Literature DB >> 12915536

Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells.

Qing Zhu1, Ju-Tao Guo, Christoph Seeger.   

Abstract

The hepatitis C virus (HCV) pandemic affects the health of more than 170 million people and is the major indication for orthotopic liver transplantations. Although the human liver is the primary site for HCV replication, it is not known whether extrahepatic tissues are also infected by the virus and whether nonprimate cells are permissive for RNA replication. Because HCV exists as a quasispecies, it is conceivable that a viral population may include variants that can replicate in different cell types and in other species. We have tested this hypothesis and found that subgenomic HCV RNAs can replicate in mouse hepatoma and nonhepatic human epithelial cells. Replicons isolated from these cell lines carry new mutations that could be involved in the control of tropism of the virus. Our results demonstrated that translation and RNA-directed RNA replication of HCV do not depend on hepatocyte or primate-specific factors. Moreover, our results could open the path for the development of animal models for HCV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915536      PMCID: PMC187424          DOI: 10.1128/jvi.77.17.9204-9210.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

Review 1.  Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties.

Authors:  K E Reed; C M Rice
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein.

Authors:  T Hügle; F Fehrmann; E Bieck; M Kohara; H G Kräusslich; C M Rice; H E Blum; D Moradpour
Journal:  Virology       Date:  2001-05-25       Impact factor: 3.616

3.  Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver.

Authors:  J Boisvert; X S He; R Cheung; E B Keeffe; T Wright; H B Greenberg
Journal:  J Infect Dis       Date:  2001-08-30       Impact factor: 5.226

4.  Effect of alpha interferon on the hepatitis C virus replicon.

Authors:  J T Guo; V V Bichko; C Seeger
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus.

Authors:  Tomasz Laskus; Marek Radkowski; Jeffrey Wilkinson; Hugo Vargas; Jorge Rakela
Journal:  J Infect Dis       Date:  2002-01-31       Impact factor: 5.226

6.  Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.

Authors:  Masanori Ikeda; MinKyung Yi; Kui Li; Stanley M Lemon
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Isolation and characterization of noncytopathic pestivirus mutants reveals a role for nonstructural protein NS4B in viral cytopathogenicity.

Authors:  L Qu; L K McMullan; C M Rice
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication.

Authors:  Marek Radkowski; Jeffrey Wilkinson; Marek Nowicki; Debra Adair; Hugo Vargas; Craig Ingui; Jorge Rakela; Tomasz Laskus
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

9.  Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

Authors:  V Lohmann; F Körner; J Koch; U Herian; L Theilmann; R Bartenschlager
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

10.  Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations.

Authors:  N Krieger; V Lohmann; R Bartenschlager
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

View more
  81 in total

1.  Study of hepatitis C virus entry in genetically humanized mice.

Authors:  Marcus Dorner; Charles M Rice; Alexander Ploss
Journal:  Methods       Date:  2012-06-08       Impact factor: 3.608

Review 2.  MicroRNAs and liver disease.

Authors:  Thomas A Kerr; Kevin M Korenblat; Nicholas O Davidson
Journal:  Transl Res       Date:  2011-02-02       Impact factor: 7.012

3.  Exiting from uncharted territory: hepatitis C virus assembles in mouse cell lines.

Authors:  Margaret A Scull; Alexander Ploss
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

4.  Virology: Final entry key for hepatitis C.

Authors:  Thomas Pietschmann
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

5.  Moving closer to a mouse model for hepatitis C.

Authors: 
Journal:  Nat Med       Date:  2009-03       Impact factor: 53.440

6.  Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons.

Authors:  Ju-Tao Guo; Qing Zhu; Christoph Seeger
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.

Authors:  George Koutsoudakis; Eva Herrmann; Stephanie Kallis; Ralf Bartenschlager; Thomas Pietschmann
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Regulation of hepatitis C virus replication by interferon regulatory factor 1.

Authors:  Nobuhiko Kanazawa; Masayuki Kurosaki; Naoya Sakamoto; Nobuyuki Enomoto; Yasuhiro Itsui; Tsuyoshi Yamashiro; Yoko Tanabe; Shinya Maekawa; Mina Nakagawa; Cheng-Hsin Chen; Sei Kakinuma; Shigeru Oshima; Tetsuya Nakamura; Takanobu Kato; Takaji Wakita; Mamoru Watanabe
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells.

Authors:  MinKyung Yi; Stanley M Lemon
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 10.  Murine models of hepatitis C: what can we look forward to?

Authors:  Markus von Schaewen; Alexander Ploss
Journal:  Antiviral Res       Date:  2014-01-24       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.